Oxford BioMedica Plc has appointed John Dawson as permanent chief executive officer with immediate effect. He joined the company as a non-executive director on 1 August 2008 and on 29 August he was named acting CEO.
Prior to joining Oxford BioMedica, Mr Dawson held senior management positions in the European operations of Cephalon Inc including that of chief financial officer and head of business development.
Copyright 2008 Evernow Publishing Ltd